| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |